Search
Search Funnelback University
- Refined by:
- Date: 2022
71 -
80 of
183
search results for news |u:www.enterprise.cam.ac.uk
Fully-matching results
-
Human CD7 monoclonal antibody YTH 30.15
https://www.enterprise.cam.ac.uk/reagents/human-cd7-monoclonal-antibody-yth-30-15/
9 May 2022:
Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.
-
HappyShield: A simple, elegant solution to PPE scarcity – Cambridge…
https://www.enterprise.cam.ac.uk/case-studies/happyshield-a-simple-elegant-solution-to-ppe-scarcity/
11 Apr 2022:
HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.
-
Semi-finalists announced in 2022 Chris Abell Postdoc Business Plan…
https://www.enterprise.cam.ac.uk/news/semi-finalists-announced-in-2022-chris-abell-postdoc-business-plan-competition/
17 Aug 2022:
In addition, applicants will benefit from even more support with our new summer programme, which offers an additional series of activities through a blend of round table discussions, one-to-one
-
Rat CD45 monoclonal antibody YTH 24.5
https://www.enterprise.cam.ac.uk/reagents/human-cd45-monoclonal-antibody-yth-24-5/
9 May 2022:
Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.
-
Human CD11a monoclonal antibody YTH 81.5
https://www.enterprise.cam.ac.uk/reagents/human-cd11a-monoclonal-antibody-yth-81-5/
9 May 2022:
Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.
-
Apollo Therapeutics: Pioneering collaboration launches its next phase …
https://www.enterprise.cam.ac.uk/case-studies/apollo-therapeutics-pioneering-collaboration-launches-its-next-phase/
11 Apr 2022:
so-called Valley of Death, the interval when promising new research can wither and die for lack of funding. ... Next steps. Apollo is now advancing into clinical development as well as identifying new programmes.
-
Human CD16 monoclonal antibody YFC 120.5
https://www.enterprise.cam.ac.uk/reagents/human-cd16-monoclonal-antibody-yfc-120-5/
9 May 2022:
Hybridoma cell line producing YFC 120.5 antibodies raised against human CD16 which are rat monoclonal antibodies of the IgG2b isotype.
-
Cambridge spin-out raises $6m seed round for transformative…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-raises-6m-seed-round-for-transformative-regulatory-data-structures/
12 Apr 2022:
University of Cambridge spin-out RegGenome announces the completion of a $6 million seed funding round.
-
Knowledge exchange in southern Africa – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/knowledge-exchange-teaching-and-learning-in-southern-africa/
11 Apr 2022:
We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.
-
FcgRlla 131R receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgrlla-131r-receptor-expressing-cell-line/
9 May 2022:
CHO cells transfected to express human FcgRlla allotype 131R as a transmembrane protein with its native intracellular domain.
9 May 2022:
Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.